CRP and esophageal squamous cell carcinoma: The CRP/Alb ratio (along with the GPS, mGPS and NLR) is a useful, simple, objective, reproducible, and economically feasible prognostic indicator in patients with ESCC that can be used in routine clinical laboratory tests.